Group One Trading’s Tempest Therapeutics TPST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-600
Closed -$4.08K 9168
2025
Q2
$4.08K Buy
600
+331
+123% +$2.35K ﹤0.01% 7172
2025
Q1
$2.58K Sell
269
-139
-34% -$1.58K ﹤0.01% 6918
2024
Q4
$4.42K Buy
408
+131
+47% +$1.69K ﹤0.01% 6462
2024
Q3
$5.04K Sell
277
-292
-51% -$5.98K ﹤0.01% 5877
2024
Q2
$16.2K Sell
569
-139
-20% -$6.01K ﹤0.01% 5360
2024
Q1
$36K Buy
708
+531
+300% +$26.8K ﹤0.01% 4980
2023
Q4
$10.1K Buy
+177
New +$8.38K ﹤0.01% 6193
2022
Q1
Sell
-246
Closed -$17K 8724
2021
Q4
$17K Hold
246
﹤0.01% 7076
2021
Q3
$46K Hold
246
﹤0.01% 6606
2021
Q2
$36K Buy
+246
New +$55.3K ﹤0.01% 6837
2021
Q1
Sell
-115
Closed -$48K 8028
2020
Q4
$48K Sell
115
-153
-57% -$52.9K ﹤0.01% 5039
2020
Q3
$85K Sell
268
-20
-7% -$6.78K ﹤0.01% 4304
2020
Q2
$99K Hold
288
﹤0.01% 3918
2020
Q1
$297K Buy
+288
New +$420K ﹤0.01% 2436
2017
Q1
Sell
-3
Closed -$14K 5005
2016
Q4
$14K Buy
3
+2
+200% +$24.9K ﹤0.01% 3845
2016
Q3
$16K Hold
1
﹤0.01% 3883
2016
Q2
$21K Hold
1
﹤0.01% 3778
2016
Q1
$18K Buy
+1
New +$21.1K ﹤0.01% 3799
2015
Q4
Sell
-30
Closed -$989K 4544
2015
Q3
$745K Buy
30
+16
+114% +$1.08M 0.01% 1476
2015
Q2
$1.19M Buy
14
+11
+367% +$1.01M 0.02% 1081
2015
Q1
$260K Buy
+3
New +$399K ﹤0.01% 2165

Other funds holding TPST

Group One Trading's TPST Position: Q2 2024 in Review

Group One Trading sold out of Tempest Therapeutics (TPST) in Q2 2024, closing a stake of 822 shares — an estimated $35.6K sold.

Group One Trading first reported a position in TPST in Q1 2015 and held it in 17 quarters. The position peaked at $945K in Q2 2015. 24 funds tracked by Wall St. Rank hold TPST as of Q2 2024.

  • Group One Trading reported no remaining Tempest Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Group One Trading sold 822 Tempest Therapeutics shares in Q2 2024, an estimated $35.6K.
  • Group One Trading first reported a position in Tempest Therapeutics in Q1 2015 and held it in 17 quarters.
  • Group One Trading's Tempest Therapeutics position peaked at $945K in Q2 2015.
  • 24 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2024.

Based on Group One Trading's 13F filing for Q2 2024, filed 14 Aug 2024.